Aligning mouse models of asthma to human endotypes of disease

Respirology

Volumn 19, Issue 6, 2014, Pages 823-833

  Martin, Rebecca A ^a   Hodgkins, Samantha R ^a,b   Dixon, Anne E ^a   Poynter, Matthew E ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b Pine Tree Veterinary Hospital   (United States)

Author keywords

asthma; glucocorticoid; hypersensitivity; lung; mouse

Indexed keywords

ADRENERGIC RECEPTOR; CORTICOSTEROID; CYCLOOXYGENASE 1; DEXAMETHASONE; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 22; LEBRIKIZUMAB; LEPTIN RECEPTOR; OMALIZUMAB; PREDNISOLONE; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR RUNX2;

ADAPTIVE IMMUNITY; ASTHMA; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DISEASE CLASSIFICATION; DRUG SAFETY; GENE EXPRESSION; HELPER CELL; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; LUNG FUNCTION; LUNG LAVAGE; MOUSE MODEL; NONHUMAN; PARTICULATE MATTER; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM CYTODIAGNOSIS; ANIMAL; CLASSIFICATION; DISEASE MODEL; METABOLISM; MOUSE; PATHOLOGY; TH17 CELL; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; HUMANS; INTERLEUKIN-17; MICE; PHENOTYPE; TH17 CELLS; TREATMENT OUTCOME;

EID: 84904513365     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12315     Document Type: Review

References (100)

1. Akinbami LJ, Moorman JE, Bailey C, Zahran HS, King M, Johnson CA, Liu X,. Trends in Asthma Prevalence, Health Care Use, and Mortality in the United States, 2001-2010. NCHS Data Brief. National Center for Health Statistics, Hyattsville, MD, 2012.
2. Barnes PJ,. Glucocorticosteroids: current and future directions. Br. J. Pharmacol. 2011; 163: 29-43.
3. Rodrigo GJ, Neffen H, Castro-Rodriguez JA,. Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review. Chest 2011; 139: 28-35.
4. Holgate ST,. Stratified approaches to the treatment of asthma. Br. J. Clin. Pharmacol. 2013; 76: 277-291.
5. Grunig G, Corry DB, Reibman J, Wills-Karp M,. Interleukin 13 and the evolution of asthma therapy. Am. J. Clin. Exp. Immunol. 2012; 1: 20-27.
6. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, Wang L, Kirkesseli S, Rocklin R, Bock B, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N. Engl. J. Med. 2013; 368: 2455-2466.
7. Holmes AM, Solari R, Holgate ST,. Animal models of asthma: value, limitations and opportunities for alternative approaches. Drug Discov. Today 2011; 16: 659-670.
8. McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, Fahy JV, Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am. J. Respir. Crit. Care Med. 2012; 185: 612-619.
9. Mullane K,. The increasing challenge of discovering asthma drugs. Biochem. Pharmacol. 2011; 82: 586-599.
10. Agache IO,. From phenotypes to endotypes to asthma treatment. Curr. Opin. Allergy Clin. Immunol. 2013; 13: 249-256.
11. Wenzel S,. Severe asthma: from characteristics to phenotypes to endotypes. Clin. Exp. Allergy 2012; 42: 650-658.
12. Barnes PJ,. Severe asthma: advances in current management and future therapy. J. Allergy Clin. Immunol. 2012; 129: 48-59.
13. Stevenson CS, Birrell MA,. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance. Pharmacol. Ther. 2011; 130: 93-105.
14. Pollart SM, Elward KS,. Overview of changes to asthma guidelines: diagnosis and screening. Am. Fam. Physician 2009; 79: 761-767.
15. Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, Lemanske RF Jr, Wardlaw AJ, Wenzel SE, Greenberger PA,. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J. Allergy Clin. Immunol. 2011; 127: 355-360.
16. Xie M, Wenzel SE,. A global perspective in asthma: from phenotype to endotype. Chin. Med. J. (Engl.) 2013; 126: 166-174.
17. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, Wardlaw AJ, Green RH,. Cluster analysis and clinical asthma phenotypes. Am. J. Respir. Crit. Care Med. 2008; 178: 218-224.
18. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, D'Agostino R Jr, Castro M, Curran-Everett D, Fitzpatrick AM, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 2010; 181: 315-323.
19. Agache I, Akdis C, Jutel M, Virchow JC,. Untangling asthma phenotypes and endotypes. Allergy 2012; 67: 835-846.
20. Jia G, Erickson RW, Choy DF, Mosesova S, Wu LC, Solberg OD, Shikotra A, Carter R, Audusseau S, Hamid Q, et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J. Allergy Clin. Immunol. 2012; 130: 647-54 e10.
21. Thomson NC, Patel M, Smith AD,. Lebrikizumab in the personalized management of asthma. Biologics 2012; 6: 329-335.
22. Corren J, Lemanske RF, Hanania NA, Korenblat PE, Parsey MV, Arron JR, Harris JM, Scheerens H, Wu LC, Su Z, et al. Lebrikizumab treatment in adults with asthma. N. Engl. J. Med. 2011; 365: 1088-1098.
23. Schett G, Elewaut D, McInnes I, Dayer J, Neurath M,. How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy. Nat. Med. 2013; 19: 822-824.
24. Hueber W, Sands BE, Lewitzky S, Vandemeulebroecke M, Reinisch W, Higgins PD, Wehkamp J, Feagan BG, Yao MD, Karczewski M, et al. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 2012; 61: 1693-1700.
25. Pillai RR, Divekar R, Brasier A, Bhavnani S, Calhoun WJ,. Strategies for molecular classification of asthma using bipartite network analysis of cytokine expression. Curr. Allergy Asthma Rep. 2012; 12: 388-395.
26. Kumar RK, Foster P,. Are mouse models of asthma appropriate for investigating the pathogenesis of airway hyper-responsiveness? Front. Physiol. 2012; 3: 1-7.
27. McAnulty RJ,. Models and approaches to understand the role of airway remodelling in disease. Pulm. Pharmacol. Ther. 2011; 24: 478-486.
28. Al Heialy S, McGovern TK, Martin JG,. Insights into asthmatic airway remodelling through murine models. Respirology 2011; 16: 589-597.
29. McKinley L, Alcorn JF, Peterson A, Dupont RB, Kapadia S, Logar A, Henry A, Irvin CG, Piganelli JD, Ray A, et al. TH17 cells mediate steroid-resistant airway inflammation and airway hyperresponsiveness in mice. J. Immunol. 2008; 181: 4089-4097.
30. Wakashin H, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N, Saito Y, Hatano M, Tokuhisa T, Iwakura Y, et al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 2008; 178: 1023-1032.
31. Yang M, Kumar RK, Foster PS,. Pathogenesis of steroid-resistant airway hyperresponsiveness: interaction between IFN-gamma and TLR4/MyD88 pathways. J. Immunol. 2009; 182: 5107-5115.
32. Ano S, Morishima Y, Ishii Y, Yoh K, Yageta Y, Ohtsuka S, Matsuyama M, Kawaguchi M, Takahashi S, Hizawa N,. Transcription factors GATA-3 and RORgammat are important for determining the phenotype of allergic airway inflammation in a murine model of asthma. J. Immunol. 2013; 190: 1056-1065.
33. Alcorn JF, Crowe CR, Kolls JK,. TH17 cells in asthma and COPD. Annu. Rev. Physiol. 2010; 72: 495-516.
34. Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP, Bleecker ER,. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J. Allergy Clin. Immunol. 2010; 125: 1028-36 e13.
35. Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Page N, Olivenstein R, Elias J, Chakir J,. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 2001; 108: 430-438.
36. Al-Ramli W, Prefontaine D, Chouiali F, Martin JG, Olivenstein R, Lemiere C, Hamid Q,. T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma. J. Allergy Clin. Immunol. 2009; 123: 1185-1187.
37. Zhao Y, Yang J, Gao YD, Guo W,. Th17 immunity in patients with allergic asthma. Int. Arch. Allergy Immunol. 2010; 151: 297-307.
38. Schnyder-Candrian S, Togbe D, Couillin I, Mercier I, Brombacher F, Quesniaux V, Fossiez F, Ryffel B, Schnyder B,. Interleukin-17 is a negative regulator of established allergic asthma. J. Exp. Med. 2006; 203: 2715-2725.
39. Newcomb DC, Boswell MG, Reiss S, Zhou W, Goleniewska K, Toki S, Harintho MT, Lukacs NW, Kolls JK, Peebles RS Jr,. IL-17A inhibits airway reactivity induced by respiratory syncytial virus infection during allergic airway inflammation. Thorax 2013; 68: 717-723.
40. Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK,. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998; 53: 849-856.
41. Dolhnikoff M, da Silva LF, de Araujo BB, Gomes HA, Fernezlian S, Mulder A, Lindeman JH, Mauad T,. The outer wall of small airways is a major site of remodeling in fatal asthma. J. Allergy Clin. Immunol. 2009; 123: 1090-1097, 7 e1.
42. Bevelander M, Mayette J, Whittaker LA, Paveglio SA, Jones CC, Robbins J, Hemenway D, Akira S, Uematsu S, Poynter ME,. Nitrogen dioxide promotes allergic sensitization to inhaled antigen. J. Immunol. 2007; 179: 3680-3688.
43. Bleck B, Tse DB, Curotto de Lafaille MA, Zhang F, Reibman J,. Diesel exhaust particle-exposed human bronchial epithelial cells induce dendritic cell maturation and polarization via thymic stromal lymphopoietin. J. Clin. Immunol. 2008; 28: 147-156.
44. Maes T, Provoost S, Lanckacker EA, Cataldo DD, Vanoirbeek JA, Nemery B, Tournoy KG, Joos GF,. Mouse models to unravel the role of inhaled pollutants on allergic sensitization and airway inflammation. Respir. Res. 2010; 11: 7.
45. Wilson RH, Whitehead GS, Nakano H, Free ME, Kolls JK, Cook DN,. Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 2009; 180: 720-730.
46. Zhao J, Lloyd CM, Noble A,. Th17 responses in chronic allergic airway inflammation abrogate regulatory T-cell-mediated tolerance and contribute to airway remodeling. Mucosal Immunol. 2012; 6: 335-346.
47. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambrecht BN,. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat. Med. 2009; 15: 410-416.
48. Kim J, McKinley L, Siddiqui J, Bolgos GL, Remick DG,. Prevention and reversal of pulmonary inflammation and airway hyperresponsiveness by dexamethasone treatment in a murine model of asthma induced by house dust. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004; 287: L503-509.
49. Moreira AP, Cavassani KA, Ismailoglu UB, Hullinger R, Dunleavy MP, Knight DA, Kunkel SL, Uematsu S, Akira S, Hogaboam CM,. The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. J. Clin. Invest. 2011; 121: 4420-4432.
50. Page K, Zhou P, Ledford JR, Day SB, Lutfi R, Dienger K, Lewkowich IP,. Early immunological response to German cockroach frass exposure induces a Th2/Th17 environment. J. Innate Immun. 2011; 3: 167-179.
51. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, Madan R, Thorne PS, Wills-Karp M, Gioannini TL, Weiss JP, et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 2009; 457: 585-588.
52. Wakahara K, Tanaka H, Takahashi G, Tamari M, Nasu R, Toyohara T, Takano H, Saito S, Inagaki N, Shimokata K, et al. Repeated instillations of Dermatophagoides farinae into the airways can induce Th2-dependent airway hyperresponsiveness, eosinophilia and remodeling in mice: effect of intratracheal treatment of fluticasone propionate. Eur. J. Pharmacol. 2008; 578: 87-96.
53. Hizume DC, Toledo AC, Moriya HT, Saraiva-Romanholo BM, Almeida FM, Arantes-Costa FM, Vieira RP, Dolhnikoff M, Kasahara DI, Martins MA,. Cigarette smoke dissociates inflammation and lung remodeling in OVA-sensitized and challenged mice. Respir. Physiol. Neurobiol. 2012; 181: 167-176.
54. Li N, Harkema JR, Lewandowski RP, Wang M, Bramble LA, Gookin GR, Ning Z, Kleinman MT, Sioutas C, Nel AE,. Ambient ultrafine particles provide a strong adjuvant effect in the secondary immune response: implication for traffic-related asthma flares. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010; 299: L374-383.
55. Matsumoto A, Hiramatsu K, Li Y, Azuma A, Kudoh S, Takizawa H, Sugawara I,. Repeated exposure to low-dose diesel exhaust after allergen challenge exaggerates asthmatic responses in mice. Clin. Immunol. 2006; 121: 227-235.
56. Moerloose KB, Pauwels RA, Joos GF,. Short-term cigarette smoke exposure enhances allergic airway inflammation in mice. Am. J. Respir. Crit. Care Med. 2005; 172: 168-172.
57. Poynter ME, Persinger RL, Irvin CG, Butnor KJ, van Hirtum H, Blay W, Heintz NH, Robbins J, Hemenway D, Taatjes DJ, et al. Nitrogen dioxide enhances allergic airway inflammation and hyperresponsiveness in the mouse. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006; 290: L144-152.
58. Jin N, Miyahara N, Roark CL, French JD, Aydintug MK, Matsuda JL, Gapin L, O'Brien RL, Gelfand EW, Born WK,. Airway hyperresponsiveness through synergy of gammadelta} T cells and NKT cells. J. Immunol. 2007; 179: 2961-2968.
59. Kim HY, Chang YJ, Subramanian S, Lee HH, Albacker LA, Matangkasombut P, Savage PB, McKenzie AN, Smith DE, Rottman JB, et al. Innate lymphoid cells responding to IL-33 mediate airway hyperreactivity independently of adaptive immunity. J. Allergy Clin. Immunol. 2012; 129: 216-27 e1-6.
60. Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M,. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009; 31: 321-330.
61. Pichavant M, Goya S, Meyer EH, Johnston RA, Kim HY, Matangkasombut P, Zhu M, Iwakura Y, Savage PB, DeKruyff RH, et al. Ozone exposure in a mouse model induces airway hyperreactivity that requires the presence of natural killer T cells and IL-17. J. Exp. Med. 2008; 205: 385-393.
62. Wingender G, Rogers P, Batzer G, Lee MS, Bai D, Pei B, Khurana A, Kronenberg M, Horner AA,. Invariant NKT cells are required for airway inflammation induced by environmental antigens. J. Exp. Med. 2011; 208: 1151-1162.
63. Martin RA, Ather JL, Daggett R, Hoyt L, Alcorn JF, Suratt BT, Weiss DJ, Lundblad LK, Poynter ME,. The endogenous Th17 response in NO2-promoted allergic airway disease is dispensable for airway hyperresponsiveness and distinct from Th17 adoptive transfer. PLoS ONE 2013; 8: e74730.
64. Willart MA, Deswarte K, Pouliot P, Braun H, Beyaert R, Lambrecht BN, Hammad H,. Interleukin-1alpha controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33. J. Exp. Med. 2012; 209: 1505-1517.
65. Yang G, Volk A, Petley T, Emmell E, Giles-Komar J, Shang X, Li J, Das AM, Shealy D, Griswold DE, et al. Anti-IL-13 monoclonal antibody inhibits airway hyperresponsiveness, inflammation and airway remodeling. Cytokine 2004; 28: 224-232.
66. Hacha J, Tomlinson K, Maertens L, Paulissen G, Rocks N, Foidart JM, Noel A, Palframan R, Gueders M, Cataldo DD,. Nebulized anti-IL-13 monoclonal antibody Fab' fragment reduces allergen-induced asthma. Am. J. Respir. Cell Mol. Biol. 2012; 47: 709-717.
67. Tomlinson KL, Davies GC, Sutton DJ, Palframan RT,. Neutralisation of interleukin-13 in mice prevents airway pathology caused by chronic exposure to house dust mite. PLoS ONE 2010; 5: e13136.
68. Gavett SH, O'Hearn DJ, Karp CL, Patel EA, Schofield BH, Finkelman FD, Wills-Karp M,. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am. J. Physiol. 1997; 272: L253-261.
69. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-2263.
70. Corry DB, Folkesson HG, Warnock ML, Erle DJ, Matthay MA, Wiener-Kronish JP, Locksley RM,. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 1996; 183: 109-117.
71. Monticelli LA, Sonnenberg GF, Artis D,. Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung. Curr. Opin. Immunol. 2012; 24: 284-289.
72. Ackerman KG, Huang H, Grasemann H, Puma C, Singer JB, Hill AE, Lander E, Nadeau JH, Churchill GA, Drazen JM, et al. Interacting genetic loci cause airway hyperresponsiveness. Physiol. Genomics 2005; 21: 105-111.
73. Ferreira CM, Chen JL, Li J, Shimomura K, Yang X, Lussier YA, Pinto LH, Solway J,. Genetic interactions between chromosomes 11 and 18 contribute to airway hyperresponsiveness in mice. PLoS ONE 2012; 7: e29579.
74. De Sanctis GT, Merchant M, Beier DR, Dredge RD, Grobholz JK, Martin TR, Lander ES, Drazen JM,. Quantitative locus analysis of airway hyperresponsiveness in A/J and C57BL/6J mice. Nat. Genet. 1995; 11: 150-154.
75. Cozzi E, Ackerman KG, Lundequist A, Drazen JM, Boyce JA, Beier DR,. The naive airway hyperresponsiveness of the A/J mouse is Kit-mediated. Proc. Natl Acad. Sci. U.S.A. 2011; 108: 12787-12792.
76. Wagers SS, Haverkamp HC, Bates JH, Norton RJ, Thompson-Figueroa JA, Sullivan MJ, Irvin CG,. Intrinsic and antigen-induced airway hyperresponsiveness are the result of diverse physiological mechanisms. J. Appl. Physiol. 2007; 102: 221-230.
77. Harrington LS, Lucas R, McMaster SK, Moreno L, Scadding G, Warner TD, Mitchell JA,. COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma. FASEB J 2008; 22: 4005-4010.
78. Hirata H, Arima M, Fukushima Y, Honda K, Sugiyama K, Tokuhisa T, Fukuda T,. Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma. Clin. Exp. Allergy 2011; 41: 1133-1142.
79. Sideleva O, Dixon A,. The many faces of asthma in obesity. J. Cell. Biochem. 2013; 115: 421-426.
80. Shore SA,. Obesity and asthma: lessons from animal models. J. Appl. Physiol. 2007; 102: 516-528.
81. Sue-Chu M,. Winter sports athletes: long-term effects of cold air exposure. Br. J. Sports Med. 2012; 46: 397-401.
82. Chimenti L, Morici G, Paterno A, Bonanno A, Siena L, Licciardi A, Veca M, Guccione W, Macaluso F, Bonsignore G, et al. Endurance training damages small airway epithelium in mice. Am. J. Respir. Crit. Care Med. 2007; 175: 442-449.
83. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Cua DJ, Ahlfors H, Wilhelm C, Tolaini M, Menzel U, et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 2011; 12: 255-263.
84. Wang YH, Voo KS, Liu B, Chen CY, Uygungil B, Spoede W, Bernstein JA, Huston DP, Liu YJ,. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 2010; 207: 2479-2491.
85. Weaver CT, Elson CO, Fouser LA, Kolls JK,. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Ann. Rev.Pathol. 2013; 8: 477-512.
86. Ramirez-Velazquez C, Castillo EC, Guido-Bayardo L, Ortiz-Navarrete V,. IL-17-producing peripheral blood CD117+ neutrophils increase in allergic asthmatic subjects. Allergy Asthma Clin Immunol. 2013; 9: 23.
87. Wang Q, Li H, Yao Y, Xia D, Zhou J,. The overexpression of heparin-binding epidermal growth factor is responsible for Th17-induced airway remodeling in an experimental asthma model. J. Immunol. 2010; 185: 834-841.
88. He R, Oyoshi MK, Jin H, Geha RS,. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc. Natl Acad. Sci. U.S.A. 2007; 104: 15817-15822.
89. Hellings PW, Kasran A, Liu Z, Vandekerckhove P, Wuyts A, Overbergh L, Mathieu C, Ceuppens JL,. Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma. Am. J. Respir. Cell Mol. Biol. 2003; 28: 42-50.
90. Mushaben EM, Brandt EB, Hershey GK, Le Cras TD,. Differential effects of rapamycin and dexamethasone in mouse models of established allergic asthma. PLoS ONE 2013; 8: e54426.
91. Yao X, Fredriksson K, Yu ZX, Xu X, Raghavachari N, Keeran KJ, Zywicke GJ, Kwak M, Amar MJ, Remaley AT, et al. Apolipoprotein E negatively regulates house dust mite-induced asthma via a low-density lipoprotein receptor-mediated pathway. Am. J. Respir. Crit. Care Med. 2010; 182: 1228-1238.
92. He R, Kim HY, Yoon J, Oyoshi MK, MacGinnitie A, Goya S, Freyschmidt EJ, Bryce P, McKenzie AN, Umetsu DT, et al. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. J. Allergy Clin. Immunol. 2009; 124: 761-70 e1.
93. Meagher LC, Cousin JM, Seckl JR, Haslett C,. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J. Immunol. 1996; 156: 4422-4428.
94. Singam R, Jena PK, Behera S, Hellermann GR, Lockey RF, Ledford D, Mohapatra SS,. Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice. Virol. J. 2006; 3: 32.
95. Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A, Wu C, Kleinewietfeld M, Kunder S, Hafler DA, et al. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 2012; 13: 991-999.
96. Tan HL, Rosenthal M,. IL-17 in lung disease: friend or foe? Thorax 2013; 68: 788-790.
97. Aujla SJ, Alcorn JF,. T(H)17 cells in asthma and inflammation. Biochim. Biophys. Acta 2011; 1810: 1066-1079.
98. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW,. Corticosteroids for preventing relapse following acute exacerbations of asthma. Cochrane Database Syst. Rev. 2007 (3); CD000195.
99. Plumb DC,. Plumb's Veterinary Drug Handbook. PharmaVet, Stockholm, WI, 2011.
100. Schimmer B, Parker K,. Adrenocorticotropic Hormone; Adrenocortical Steroids and Their Synthetic Analogues; Inhibitors of the Syntheses and Actions of Adrenocortical Hormones. McGraw-Hill, Columbus, OH, 2006.